on December 10, 2007
Published online before print December 10, 2007, doi: 10.1161/CIRCULATIONAHA.107.738559
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 4, 2007
From the Boston Adult Congenital Heart Service, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and Children’s Hospital Boston, Harvard Medical School, Boston, Mass. * To whom correspondence should be addressed. E-mail: paul.khairy{at}cardio.CHBoston.org
or michael.landzberg{at}cardio.CHBoston.org.
Background—To better define determinants of mortality in patients with univentricular physiology, a database registry was created of patients born in 1985 or earlier with Fontan surgery who were followed up at Children’s Hospital Boston. Methods and Results—A total of 261 patients, 121 of whom (46.4%) were women, had a first Fontan surgery at a median age of 7.9 years: right atrium–to–pulmonary artery connection in 135 (51.7%); right atrium to right ventricle in 25 (9.6%); and total cavopulmonary connection in 101 (38.7%). Over a median of 12.2 years, 76 (29.1%) died, 5 (1.9%) had cardiac transplantation, 5 (1.9%) had Fontan revision, and 21 (8.0%) had Fontan conversion. Perioperative mortality decreased steadily over time and accounted for 68.4% of all deaths. In early survivors, actuarial freedom from death or transplantation was 93.7%, 89.9%, 87.3%, and 82.6% at 5, 10, 15, and 20 years, respectively, with no significant difference between right atrium to pulmonary artery versus total cavopulmonary connection. Late deaths were classified as sudden in 7 patients (9.2%), thromboembolic in 6 (7.9%), heart failure–related in 5 (6.7%), sepsis in 2 (2.6%), and other in 4 (5.2%). Most sudden deaths were of presumed arrhythmic origin with no identifiable predictor. Independent risk factors for thromboembolic death were lack of antiplatelet or anticoagulant therapy (hazard ratio [HR], 91.6; P=0.0041) and clinically diagnosed intracardiac thrombus (HR, 22.7; P=0.0002). Independent predictors of heart failure death were protein-losing enteropathy (HR, 7.1; P=0.0043), single morphologically right ventricle (HR, 10.5; P=0.0429), and higher right atrial pressure (HR, 1.3 per 1 mm Hg; P=0.0016). Conclusion—In perioperative survivors of Fontan surgery, gradual attrition occurs predominantly from thromboembolic, heart failure–related, and sudden deaths.
Accepted on October 22, 2007
Long-Term Survival, Modes of Death, and Predictors of Mortality in Patients With Fontan Surgery
Paul Khairy MD, PhD*,
Key words: death, sudden • Fontan procedure • heart failure • mortality • survival • thrombosis
Related Article:
Circulation 2008 117: 1-3.
This article has been cited by other articles:
 |
|
 |
|
  J. Bouchardy, J. Therrien, L. Pilote, R. Ionescu-Ittu, G. Martucci, N. Bottega, and A. J. Marelli Atrial Arrhythmias in Adults With Congenital Heart Disease Circulation, October 27, 2009; 120(17): 1679 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Griffiths, A. K. Kaza, M. C. Wyler von Ballmoos, H. Loyola, A. M. Valente, E. D. Blume, and P. del Nido Evaluating failing Fontans for heart transplantation: predictors of death. Ann. Thorac. Surg., August 1, 2009; 88(2): 558 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Lacour-Gayet, C. J. Lanning, S. Stoica, R. Wang, B. A. Rech, S. Goldberg, and R. Shandas An artificial right ventricle for failing fontan: in vitro and computational study. Ann. Thorac. Surg., July 1, 2009; 88(1): 170 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kerendi, Z. B. Kramer, W. T. Mahle, B. E. Kogon, K. R. Kanter, and P. M. Kirshbom Perioperative risks and outcomes of atrioventricular valve surgery in conjunction with Fontan procedure. Ann. Thorac. Surg., May 1, 2009; 87(5): 1484 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Odegard, D. Zurakowski, J. A. DiNardo, R. A. Castro, F. X. McGowan Jr., E. J. Neufeld, and P. C. Laussen Prospective longitudinal study of coagulation profiles in children with hypoplastic left heart syndrome from stage I through Fontan completion J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 934 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Hsu and G. D. Pearson Heart Failure in Children: Part I: History, Etiology, and Pathophysiology Circ Heart Fail, January 1, 2009; 2(1): 63 - 70. [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Deanfield, R. Yates, F. J. Meijboom, and B. J.M. Mulder CHAPTER 10 Congenital Heart Disease in Children and Adults ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Graham Jr The Year in Congenital Heart Disease J. Am. Coll. Cardiol., October 28, 2008; 52(18): 1492 - 1499. [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Silka and Y. Bar-Cohen Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?: Patients With Congenital Heart Disease and a Systemic Ventricular Ejection Fraction Less Than 30% Should Undergo Prophylactic Implantation of an Implantable Cardioverter Defibrillator Circ Arrhythm Electrophysiol, October 1, 2008; 1(4): 298 - 306. [Full Text] [PDF]
|
|
|
|
|
|
P. Khairy and M. J. Landzberg Adult Congenital Heart Disease: Toward Prospective Risk Assessment of a Multisystemic Condition Circulation, May 6, 2008; 117(18): 2311 - 2312. [Full Text] [PDF]
|
|
|
|
|
|
W. M. Gersony Fontan Operation After 3 Decades: What We Have Learned Circulation, January 1, 2008; 117(1): 13 - 15. [Full Text] [PDF]
|
|